CapitolRadar tracks every publicly disclosed CL trade by US congress members and corporate insiders: 58 disclosed trades (33 buys, 25 sells) by 6 tracked traders, from 2019-08-06 to 2026-09-25. Updated daily from official filings.
🔥 In the news right now: CL picked up 45 news headlines in the last 48 hours. Attention is not evidence. It tells you what people are looking at, not whether they are right.
Want a ping when Congress buys CL? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
Colgate-Palmolive Company (CL) — Consumer Defensive · Household & Personal Products, market cap about $72.0B.
Cluster watch: 8 distinct tracked traders disclosed buying CL in the last 45 days: Wallace Noel R. (director, officer: Chairman, President & CEO), GRANT SHANE (officer: COO, Americas), Tsourapas Panagiotis (officer: COO, CD, EMEA, APac, Skin), SUTULA STANLEY J III (officer: Chief Financial Officer), Hazlin John (officer: Chief Growth Officer), Massey Sally (officer: Chief People Officer).
CapitolRadar analysis
34 trades skewed toward purchases
34 tracked CL trades comprise 23 buys and 11 sells by three distinct traders between March 29, 2021 and June 2, 2026. Purchases therefore account for 23 of the 34 disclosed transactions. The activity concerns Colgate-Palmolive Company, classified in the Consumer Defensive sector and Household & Personal Products industry. Although the full period spans more than five years, only three traders appear in the dataset, so the sample is too small to support broad conclusions about congressional or insider sentiment.
8 listed quarters show uneven activity
5 trades in 2025 Q3 represent the busiest quarter among those provided, with four buys and one sell. The other listed periods contain one or two trades each: 2026 Q2 had one buy; 2026 Q1 had two trades, including one buy; 2025 Q4 had one sell; 2025 Q2 and 2024 Q1 each had one buy; 2023 Q4 had two buys; and 2023 Q3 had two sells. These listed quarters account for only part of the 34-trade history, and the quarter-level counts remain small.
22 of 23 buys came from one disclosed buyer
Ro Khanna recorded 22 buys, with the latest dated June 2, 2026. John Boozman recorded one buy, dated April 8, 2025. Together, those disclosed buyer totals equal all 23 tracked buys. One of these buyers also purchased each of AME, BBY, CMCSA, DHI, FHN and ICE, but the provided data does not identify which buyer or give counts beyond one buyer per ticker.
Trade disclosures can lag transactions by up to 45 days, so the record is not real-time. Transaction amount ranges, when reported, are estimates rather than exact values; no amount ranges are provided here. The limited number of traders and quarter-level observations warrants particular caution when interpreting patterns.
Analysis written from the tracked record on 2026-08-31; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q3 | 7 | 0 | 7 |
| 2026 Q2 | 1 | 1 | 0 |
| 2026 Q1 | 2 | 1 | 1 |
| 2025 Q4 | 1 | 0 | 1 |
| 2025 Q3 | 5 | 4 | 1 |
| 2025 Q2 | 1 | 1 | 0 |
| 2024 Q1 | 1 | 1 | 0 |
| 2023 Q4 | 2 | 2 | 0 |
Who is buying CL?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Ro Khanna | 22 | 2026-06-02 | — |
| Lois Frankel | 6 | 2021-04-07 | — |
| Kevin Hern | 4 | 2019-10-15 | — |
| John Boozman | 1 | 2025-04-08 | — |
Disclosed trades in CL
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2026-09-11 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2026-09-02 | Kevin Hern | sell | $1,001 - $15,000 | — |
| 2026-08-31 | Kevin Hern | sell | $1,001 - $15,000 | — |
| 2026-08-27 | Kevin Hern | sell | $1,001 - $15,000 | — |
| 2026-08-19 | Kevin Hern | sell | $1,001 - $15,000 | — |
| 2026-08-18 | Kevin Hern | sell | $1,001 - $15,000 | — |
| 2026-06-02 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-01-29 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2026-01-13 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-10-07 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2025-09-29 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2025-09-05 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-08-26 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-07-24 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-07-08 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-04-08 | John Boozman | buy | $1,001 - $15,000 | — |
| 2024-01-10 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-10-31 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2023-10-02 | Ro Khanna | buy | $1,001 - $15,000 | — |
CapitolRadar signal history
NEW PICK 2026-09-21
Colgate-Palmolive EVP and Controller Malcolm Gregory reportedly bought about $650,649 of CL stock. The panel passed because the listed September 2026 trade and disclosure dates are future-dated, so the purchase cannot yet be verified. A valid regulatory filing confirming the transaction, dates, share count, and price would have been the key evidence needed to change the verdict.
These buyers also bought
Other stocks the tracked buyers of CL disclosed buying in the last six months: CB (2) · FSLR (2) · KO (2) · OTIS (2) · ADI (1) · APP (1).
About Colgate-Palmolive Company
Operating globally, Colgate-Palmolive Company and its affiliated entities are engaged in the production and distribution of a diverse range of consumer goods. Its operations are structured into two primary divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care division encompasses a broad array of offerings, spanning oral hygiene (e.g., toothpastes, toothbrushes, mouthwashes), personal care (e.g., bar and liquid soaps, shower gels, shampoos, conditioners, deodorants, antiperspirants, skin health items), and home care solutions (e.g., dishwashing detergents…
Frequently asked questions
Which politicians bought CL most?
Ro Khanna leads with 22 disclosed buys, followed by Lois Frankel.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.